{"name":"KIMJisun","slug":"kimjisun","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Melatonin(Circadin®)","genericName":"Melatonin(Circadin®)","slug":"melatonin-circadin","indication":"Insomnia characterized by poor quality of sleep in patients aged 55 years and older","status":"marketed"}]}],"pipeline":[{"name":"Melatonin(Circadin®)","genericName":"Melatonin(Circadin®)","slug":"melatonin-circadin","phase":"marketed","mechanism":"Melatonin is a natural hormone that binds to melatonin receptors (MT1 and MT2) in the brain to regulate circadian rhythm and promote sleep.","indications":["Insomnia characterized by poor quality of sleep in patients aged 55 years and older"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1rZDduZjRaRHZ4azYxeWluX0l6MFlfcFAwVkpIeDh2Z1VYaDVJQWtaOUF3SXM3OEoxOHhFWm9oRVVDV3E5bEZUUmtyMXNHbTVTajJsQWpMcHlOeUJEUmhUNE5CN0FWTGxRZ1E0Qmln0gFuQVVfeXFMTWtkN25mNFpEdnhrNjF5aW5fSXowWV9wUDBWSkh4OHZnVVhoNUlBa1o5QXdJczc4SjE4eEVab2hFVUNXcTlsRlRSa3Ixc0dtNVNqMmxBakxweU55QkRSaFQ0TkI3QVZMbFFnUTRCaWc?oc=5","date":"2026-04-06","type":"pipeline","source":"알파경제","summary":"Samchundang Pharma Faces Ongoing Doubts Over S-PASS Platform Despite Press Briefing - 알파경제","headline":"Samchundang Pharma Faces Ongoing Doubts Over S-PASS Platform Despite Press Briefing - 알파경제","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}